Russell Investments Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,411
Closed -$1.71K 3926
2024
Q4
$1.71K Sell
3,411
-150
-4% -$75 ﹤0.01% 3468
2024
Q3
$13.3K Sell
3,561
-6,237
-64% -$23.3K ﹤0.01% 3036
2024
Q2
$54.9K Buy
9,798
+7,486
+324% +$41.9K ﹤0.01% 2743
2024
Q1
$12.1K Sell
2,312
-11,828
-84% -$62K ﹤0.01% 2827
2023
Q4
$73.9K Sell
14,140
-1,325
-9% -$6.93K ﹤0.01% 2599
2023
Q3
$244K Buy
15,465
+14,851
+2,419% +$234K ﹤0.01% 2448
2023
Q2
$11.9K Sell
614
-2,879
-82% -$56K ﹤0.01% 2930
2023
Q1
$99.1K Sell
3,493
-6,800
-66% -$193K ﹤0.01% 2592
2022
Q4
$301K Buy
10,293
+6,800
+195% +$199K ﹤0.01% 2460
2022
Q3
$92K Sell
3,493
-2,933
-46% -$77.3K ﹤0.01% 2679
2022
Q2
$283K Sell
6,426
-4,587
-42% -$202K ﹤0.01% 2460
2022
Q1
$543K Sell
11,013
-2,083
-16% -$103K ﹤0.01% 2199
2021
Q4
$664K Sell
13,096
-5,972
-31% -$303K ﹤0.01% 2339
2021
Q3
$1.06M Sell
19,068
-23,845
-56% -$1.33M ﹤0.01% 2158
2021
Q2
$1.82M Sell
42,913
-54,620
-56% -$2.32M ﹤0.01% 1969
2021
Q1
$4.06M Buy
97,533
+12,321
+14% +$513K 0.01% 1463
2020
Q4
$3.96M Sell
85,212
-6,676
-7% -$311K 0.01% 1374
2020
Q3
$3.89M Buy
91,888
+2,353
+3% +$99.7K 0.01% 1278
2020
Q2
$4.29M Buy
89,535
+24,040
+37% +$1.15M 0.01% 1186
2020
Q1
$3.01M Buy
65,495
+8,803
+16% +$405K 0.01% 1244
2019
Q4
$3.41M Sell
56,692
-13,972
-20% -$839K 0.01% 1433
2019
Q3
$4M Buy
70,664
+30,819
+77% +$1.74M 0.01% 1313
2019
Q2
$2.22M Buy
39,845
+17,190
+76% +$957K ﹤0.01% 1623
2019
Q1
$1.14M Buy
22,655
+8,348
+58% +$422K ﹤0.01% 1995
2018
Q4
$576K Buy
14,307
+12,483
+684% +$503K ﹤0.01% 2263
2018
Q3
$126K Sell
1,824
-4,008
-69% -$277K ﹤0.01% 2725
2018
Q2
$441K Buy
5,832
+53
+0.9% +$4.01K ﹤0.01% 2435
2018
Q1
$304K Buy
5,779
+4,908
+563% +$258K ﹤0.01% 2595
2017
Q4
$48K Sell
871
-41
-4% -$2.26K ﹤0.01% 2872
2017
Q3
$54K Sell
912
-45,172
-98% -$2.67M ﹤0.01% 2851
2017
Q2
$3.63M Buy
46,084
+45,466
+7,357% +$3.59M 0.01% 1402
2017
Q1
$51K Sell
618
-23,935
-97% -$1.98M ﹤0.01% 2901
2016
Q4
$1.94M Buy
+24,553
New +$1.94M ﹤0.01% 1822